Association of Alzheimer's disease GWAS loci with MRI markers of brain aging

Journal article (2015)

Authors

Ganesh Chauhan Université de Bordeaux
Hieab H H Adams Erasmus MC
H. H H Adams Erasmus MC
Hieab H. Adams Erasmus MC
H Adams Erasmus MC
More Authors... External organisation
Joshua C. Bis University of Washington
Galit Weinstein Framingham Heart Study, Boston University School of Medicine
Lei Yu Rush University Medical Center
Anna Maria Töglhofer Medical University Graz
Albert Vernon Smith Icelandic Heart Association
S.J. Van Der Lee Erasmus MC
S.J. van Der Lee Erasmus MC
S.J. van der Lee Erasmus MC
Rebecca F. Gottesman Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University
Wiro J.N. Niessen ImPhys/Quantitative Imaging , Erasmus MC
WJ Niessen ImPhys/Quantitative Imaging , Erasmus MC
W.J. Niessen ImPhys/Quantitative Imaging , Erasmus MC
Wiro J. Niessen ImPhys/Quantitative Imaging , Erasmus MC
Wiro Niessen ImPhys/Quantitative Imaging , Erasmus MC
W. J. Niessen ImPhys/Quantitative Imaging , Erasmus MC
Affiliation
External organisation
More Info
expand_more

Published Date

2015

Language

English

Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Affiliation

External organisation

Abstract

Whether novel risk variants of Alzheimer's disease (AD) identified through genome-wide association studies also influence magnetic resonance imaging-based intermediate phenotypes of AD in the general population is unclear. We studied association of 24 AD risk loci with intracranial volume, total brain volume, hippocampal volume (HV), white matter hyperintensity burden, and brain infarcts in a meta-analysis of genetic association studies from large population-based samples (N= 8175-11,550). In single-SNP based tests, AD risk allele of APOE (rs2075650) was associated with smaller HV (. p= 0.0054) and CD33 (rs3865444) with smaller intracranial volume (. p= 0.0058). In gene-based tests, there was associations of HLA-DRB1 with total brain volume (. p= 0.0006) and BIN1 with HV (. p= 0.00089). Aweighted AD genetic risk score was associated with smaller HV (beta ± SE=-0.047 ± 0.013, p= 0.00041), even after excluding the APOE locus (. p= 0.029). However, only association of AD genetic risk score with HV, including APOE, was significant after multiple testing correction (including number of independent phenotypes tested). These results suggest that novel AD genetic risk variants may contribute to structural brain aging in nondemented older community persons.